Skip to main content

Naltrexone News

Hospital Addiction Consultation Service Aids Opioid Use Disorder

WEDNESDAY, April 16, 2025 – A hospital-based addiction consultation service can improve receipt of evidence-based treatment for people with opioid use disorder (OUD), according to a study published...

Inmates in Many U.S. Jails Have No Access to Meds That Fight Opioid Addiction

TUESDAY, Sept. 24, 2024 – Opioid use disorder can be a contributing factor to Americans landing in the nation's prisons and jails, but those inmates typically have no access to medications that...

FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....

FDA Approves Contrave (bupropion/naltrexone) for Weight Management

September 10, 2014 – The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic...

FDA Approves Vivitrol to Treat Opioid-dependent Patients

ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Drug Administration today approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Alcohol Dependence, Fibromyalgia, Smoking Cessation, Opiate Dependence

Related drug support groups

Vivitrol

Naltrexone patient information at Drugs.com